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IgG aggregates and immune complexes have been shown to stimulate cells in vitro 
(1-3). This includes the platelet, a cell that secretes a variety of constituents in response 
to  these  stimuli.  For  example,  human  platelet  secretion  is  initiated  by  immune 
complexes and IgG aggregates (1), by aggregated Fc fragments (4, 5) but not aggregated 
F(ab')2 fragments, leading to the concept of a platelet "Fc receptor" (5, 6). This concept 
has recently been  strengthened by the demonstration that aggregated IgG binds to 
human platelets and that binding is inhibited more strongly by human IgG than by 
F(ab')2 fragments or bovine IgG (7). The nature of the postulated platelet Fc receptor 
remains unclear, but the fact that the first component of the classical complement path- 
way, C1, like the platelet, is activated by aggregated IgG or Fc fragments, has led to the 
hypothesis that C1 bound to the platelet surface plays a critical role in the platelet re- 
sponse to aggregated IgG (8). There is, however, little information on the effects of other 
activators of C1 on platelet function. 
The  lipopolysaccharide  (LPS)  1 component of gram-negative bacteria  is  a 
molecule that may be responsible for many of the pathogenic properties of the 
whole  organism  (9). LPS  from  smooth bacterial  strains  consists  of a  type- 
specific O  antigen, a  strain-specific core polysaccharide, a  trisaccharide of 2- 
keto-3-deoxy octulosonate (KDO), and a  lipid termed "lipid A" (10). The KDO- 
lipid A portion of the molecule is remarkably similar in most bacterial strains 
(9) and may be obtained in isolated form as the LPS of heptose-deficient rough 
mutants such as Salmonella minnesota R595. This lipid-rich LPS and lipid A iso- 
lated by acid hydrolysis of LPS (10) have been shown to provide many of the 
strain independent activities of LPS (11). Both lipid A and lipid A-rich LPS from 
S. minnesota R595 have recently been shown to activate complement via C1 (12, 
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13). In this paper, we report data showing that lipid A and lipid A-rich LPS 
from S.  minnesota  R595  (LPS  R595)  by themselves are  not potent platelet 
stimuli. These bacterial products are shown, however, to dramatically poten- 
tiate the effectiveness of IgG aggregates and immune complexes as initiators of 
the platelet release reaction. 
Materials and Methods 
Chemicals.  Phenol  and  chloroform  were  from  Mallinckrodt  Inc.  (St.  Louis,  Me.)  and  the 
petroleum ether (bp  =  20-40°C)  from J. T.  Baker Chemical Co.  (Phillipsburg,  N. J.).  Schwartz 
Mann Div. Becton, Dickinson & Co. (Orangeburg, N. Y.) provided the tris hydroxymethyl amino 
methane  (Tris,  Ultra Pure)  and  E.  R.  Squibb  &  Sons  (Princeton,  N.  J.) provided the human 
Cohn fraction II (lot no. 2030). The [3H]serotonin binoxalate (1 Ci/mM) in 2% ethanol and the ~31I 
(12-25  Ci/mg) were from New England Nuclear  (Boston,  Mass.).  Bovine serum albumin  (BSA; 
was  recrystallized  three  times  and  was  from  Armour  Pharmaceuticals  Company  (Phoenix, 
Ariz.). 
Lipopolysaccharide.  LPS  of S.  minnesota  R595  was  extracted  from  bacterial  paste  (New 
England  Enzyme Center,  Boston,  Mass.)  by the phenol-chloroform-petroleum ether  procedure 
(14). The purified LPS was suspended at a  concentration of 2.5 mg/ml in 0.9%  NaC1 containing 
0.1%  triethylamine,  sonicated,  and  subsequently  dialyzed  extensively  against  0.9%  NaC1  to 
remove unbound  triethylamine.  Lipid  A  was  prepared  by  acid  hydrolysis  (15)  of Salmonella 
typhimurium  R60 LPS and dispersed in 1% triethylamine and dialyzed against 0.9% NaC1. 0.1- 
1% triethylamine alone had no effect on platelet serotonin release in the presence or absence of 
IgG aggregates. 
Gamma Globulin.  Purified polyclonal gamma globulin was obtained by diethylamino ethyl 
cellulose chromatography of Cohn fraction II. This material produced a  si~gle precipitin arc on 
immunoelectrophoresis  at  20  mg/ml  when  reacted  with  goat  whole  anti-human  serum.  IgG 
myeloma proteins of greater than 95%  homogeneity by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis were generously provided by Dr. Hans Spiegelberg of the Scripps Clinic. Pro- 
teins were heat aggregated at 63°C for 30 min at 20 mg]ml in 0.01  M sodium phosphate 0.15  M 
NaCl pH 7.  Isolated soluble IgG aggregates were prepared  by fractionation of heat-aggregated 
IgG on a  4.5  x  75-cm column containing  Ultregel Ac A22  (LKB Instruments,  Inc.,  Rockville, 
Md.).  Protein eluting at apparent  reel wt of 500,000-1,500,000  daltons  was pooled, frozen,  and 
stored at -70°C until use. 
Other Platelet Stimuli.  Monosodium urate crystals were prepared as described (16). Insoluble 
human  skin  collagen  extracted  by  the  Nishihara  procedure  was  generously  provided  by  Dr. 
George Wilner through Dr. John Griffin of the Scripps Clinic. Crude bovine thrombin was from 
Parke,  Davis & Company (Detroit,  Mich.). Anti-human platelet antibodies were raised in New 
Zealand white rabbits  (Rancho de Conejo, La Jells, Calif.). These antisera were absorbed with 
human red blood cells until they did not agglutinate human neutrophils or red blood cells. In addi- 
tion, no precipitin lines were observed when these antisera were reacted against human plasma 
in immunodiffusion analysis. 
Protein Labeling.  IgG was labeled with ~31I by the procedure of McConahey and Dixon (17). 
BSA-Anti-BSA  Complexes.  Antisera  to  BSA  were  raised  in  New  Zealand  white  rabbits 
(Rancho  de  Conejo) and  contained  417  ~g  of antibody  nitrogen/ml  by  quantitative  precipitin 
analysis. Immune complexes were precipitated at equivalence using this antiserum and washed 
twice in 0.15 M NaC1 0.01 M sodium phosphate pH 7 before platelet release experiments. 
Platelet Release Experiments.  These were done with plastic  apparatus.  Blood from normal 
donors who had taken no medication in the previous week was drawn through a 20-gauge needle 
into 1/6 vol acid citrate dextrose (18). Platelet-rich plasma was isolated by centrifugation at 200 g 
in an International centrifuge (International Equipment Co., Boston, Mass.) for 15 rain at room 
temperature  and  was incubated  at 37°C for 30  min with 0.1  ~Ci/ml  [3H]seretonin  resulting in 
uptake of 80-90% of radioactivity. Platelets were pelleted by centrifugation at 1,000 g  for 15 min 
at 10°C in an International  centrifuge, and the platelet button resuspended in 30 mM Tris,  120 
mM NaCl, 5 mM glucose (TBS) pH 6.5.  The platelets were then recentrifuged and resuspended 
twice before being centrifuged and finally suspended  at 2  ×  103 ceUs/ml in TBS pH 7.4.  These 
suspensions contained less than one white cell per 2,000 platelets. 100- 
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FIG. i.  Response of  platelets  to LPS R595. LPS R595 at  the final  concentration shown on 
the abscissa  was mixed with varying quantities of polyclonal human  IgG.  Platelet 
suspensions were  added  and  percent  serotonin  release  determined  after  a 15-rain  incubation 
at 37°C. (Preliminary studies  had shown a plateau in serotonin  release  induced  by these 
stimuli after  a 10-rain  incubation).  Mean ± SEM  of  triplicate  determinations. Where no 
error  bars appear, the error  is  within  the point. 
In general, 100 ~l of  test  substance was added to 12 x 75-ram Falcon  polystyrene (Sherwood 
Medical Industries,  Inc.,  St. Louis,  Mo.) tubes and incubated at 37°C for 10 rain,  at which time 
400/~l  of  the prewarmed platelet  suspension  was added and the mixture incubated with shaking 
at  37°C in  a Dubnoff  metabolic incubator.  At appropriate  times,  the  tubes  were  placed into  ice  for 
2-5 rain  and centrifuged  at  5,000  g for  15 rain  at  4°C.  To 2 ml of  a mixture  of  equal  parts  Aquasol 
(New England Nuclear) and  toluene,  100 ~l  of  supernate  was added and  the  mixture  counted  in  a 
Searle Delta 300 liquid  scintillation  spectrometer  (Searle Analytic Inc.,  Des Plaines, Ill.). 
Percent-spocific  release  of  serotonin  was defined as: 
radioactivity  in stimulus-treated  supornate - 
radioactivity  in  buffer-troated  supernate x 100 
total  radioactivity  releasable  by 0.2% Triton X-100 - 
radioactivity  in  buffer-treated  supernate 
In some experiments, loss  of  lactic  dehydrogenase (LDH) was assayed as well (16).  Data were 
analyzed  only from those platelet  preparations in  which less  than 10% of  total  serotonin  or LDH 
was in  buffer-treated  supornates. 
Results 
Effect of LPS R595 and Lipid A  on Washed Human Platelets.  The ability 
of LPS R595  and lipid A  to initiate serotonin secretion from washed human 
platelets was studied. Fig. 1 shows that addition of mixtures of human gamma 
globulin preparations  (which induced little  serotonin release by themselves) 
and LPS  R595  to  the  cells resulted in  significant serotonin release  at  LPS 
concentrations as low as 10 ~g/ml. The cytoplasmic enzyme, LDH, was retained 
at all doses of LPS and gamma globulin employed. The LPS alone showed little 
activity at the concentrations tested. Similar data were obtained with platelets 
washed by the techniques of Mustard et al.  (19) and Walsh (20). The lipid A 
preparation was comparable to LPS R595 in activity (not shown). 
The gamma globulin preparations may have contained antilipid A antibodies 
(21) which in the presence of lipid A  could have formed immune complexes, 
thus leading to the observed platelet stimulation. To explore this possibility, 
the  nature  of the  active  material  in  the  gamma globulin preparation was 
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FIG.  2.  Size  of the  component  of  gamma  globulin  in  preparation  inducing  serotonin 
release in the presence of LPS R595.  10 ml of 20 mg/ml gamma globulin were placed on a 
4.5 x  100-cm column containing Sephadex G200, and 20-ml fractions collected. 100 ~l of each 
fraction  was  mixed  with  50  /~l  500  I~g  LPS  R595/ml.  Percent  serotonin  release  was 
determined 15 min after addition of 350 #al of platelet suspension. Each point is the mean 
of duplicate determinations (©  ..... ©, percent serotonin release; $  ,,  absorbance at 280 
rim). 
Size of the Active Material  in Gamma Globulin  Preparations.  When the 
gamma  globulin  preparations  were  passed  over  a  Sephadex  G200 column 
(Pharmacia Fine Chemicals, Inc., Piscataway, N. J.; Fig. 2), serotonin releasing 
activity in the presence of LPS R595 appeared only in fractions eluting before 
IgG monomer. This suggested that the active material was IgG aggregates or a 
large non-IgG trace contaminant. To help distinguish these possibilities,  the 
inactive fraction containing IgG monomer was heated at 63°C. Heating for as 
little as 5 min resulted in serotonin releasing activity when the protein was 
mixed with LPS R595. This suggested that LPS R595 worked to enhance the 
platelet's  response  to  IgG  aggregates.  The  remote  possibility  that  heating 
activated some previously inert contaminant, or altered antilipid A antibodies, 
still  remained. To  rule out this  possibility,  the  effect of LPS  R595 platelet 
response to heated myeloma proteins was assessed. 
IgG myeloma proteins were heat aggregated at 63°C for 30 min. Fig. 3 shows 
that LPS R595 enhanced platelet serotonin release in response to these heat- 
aggregated proteins. This provided strong evidence that LPS R595 or lipid A 
effect on platelets was mediated through IgG. 
Effect  of  LPS  R595  and  Lipid  A  on  Platelet  Response  to  IgG 
Aggregates.  Because our polyclonal gamma globulin preparations and heated 
myeloma proteins were mixtures of IgG monomer and aggregates, the effects of 
LPS R595 and lipid A  on platelet response to  purified IgG aggregates were 
quantitated. These results are shown in Fig. 4. LPS R595 or lipid A induced a 
50-fold increase in platelet sensitivity to IgG aggregates. 
Effect of Size of IgG Aggregates  on Platelet Stimulation in the Presence and 
Absence of LPS.  Because IgG aggregates bind to LPS R595 and lipid A, 2 the 
2 M. H. Ginsberg and D. C. Morrison. The binding of aggregated IgG to lipid A-rich bacterial 
lipopolysaccharide.  Submitted for publication. ._= 
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FIG.  3.  Effect of LPS R595 on platelet response to heat-aggregated  myeloma proteins.  50 
~l of 250 ~g/ml LPS R595 or of saline was mixed with 50 ~l of 200 ~g/ml heat-aggregated 
myeloma proteins.  Percent  serotonin  release  determined  15  min after  addition of 400-~1 
platelet suspension.  Mean  _  SEM of triplicate determinations. 
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FIG.  4.  Effect  of LPS  R595  and  lipid A  on  platelet  response  to  soluble  polyclonal  IgG 
aggregates.  50 ~1 of LPS R595 (O  O) or lipid A  (I------I)  at 500 ~g/ml was mixed with 
50  ~l soluble IgG  aggregates  (final concentration  shown on  abscissa).  Percent  serotenin 
release was determined  15 rain after addition of 400-~1 platelet suspension.  Mean  _+ SEM 
of triplicate determinations. 
possibility  arises  that this  enhancement  is  due to  increased  apparent  size  of 
aggregates  in the presence of lipid A.  To examine this,  the size requirements 
for IgG aggregate-induced  platelet stimulation in the presence and absence of 
LPS were  studied.  To assess these  requirements,  131I-IgG was heated at 63°C 
for 30 min and fractionated by gel filtration (Fig. 5) chromatography. Serotonin 
releasing  activity was present in fractions larger than IgG monomer and was 
enhanced by the addition of LPS R595. Subsequently, dilutions of fractions corre- 
sponding in size to large (apparent M r >106 daltons-fraction 26) soluble aggre- 
gates,  small  (apparent M r 3-6  ×  105 daltons-fraction  38) soluble aggregates, 
and IgG (fraction 46) monomer were added to platelet suspensions in the pres- 
ence and absence of LPS. Inasmuch as IgG aggregates are unstable, the sizes of 
these three aggregate populations were reassessed on sucrose density gradients 212  ENHANCEMENT  OF  PLATELET  RESPONSE  BY  LIPOPOLYSACCHARIDES 
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Fro.  5.  Gel  filtration  of  heated  gamma  globulin.  ~3~I-polyclonal  gretna  globulin  was 
heated  at  20  mg/ml  63°C  for  30  rain.  10  ml  was  then  placed  on  a  4.5  x  80-cm  column 
containing  Ultrogel  Ac  A22  and  20-ml  fractions  collected.  Protein  was  determined  by 
absorbance  at 280 nM (0  0) or radioactivity  (not  shown).  50 kel  of  each  fraction  was 
mixed with  50  0.1  0.9%  NaC1  (A  ..... A)  or  250  ~g/ml  LPS  t!595  in  saline  (©  ©),  and 
percent serotonin release determined  15 rain after addition of 400-~tl platelet suspension. 
Results are mean of duplicate determinations. 
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FIG.  6.  Response of  platelets to various sized IgG aggregates. 100/~I of  various dilutions 
of  IgG fractions (see Fig. 5) were added to 50/~l 0.9% NaCl, and percent serotonin release 
determined  15 rain after addition of 350-/~I  platelet suspension.  Protein concentrations 
represent the final  concentration in the 500-/~I  incubation mixture. Results are mean of 
duplicate determinations (O  ....  O, fraction 26; •  0, fraction 38; • .....  0, fraction 46). 
at  the  time they  were added to  the  platelet  suspensions. Fig.  6  shows that,  in  the 
absence of LPS, small soluble IgG aggregates were as effective  on a weight 
basis as larger aggregates in stimulating platelets.  Fig. 7 indicates  that in the 
presence  of  LPS R595, the  small and large aggregates  were again approximately 
equally effective  and some 20-fold  more active  than the same proteins in the 
absence of  LPS. Fig. 8 documents the size  of  the various column fractions,  as 
assessed on sucrose density gradients in the absence of  LPS, at the same time 
they were added to the platelet suspensions. Because LPS R595 selectively 106" 
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FIG. 7.  Response of platelets  to various sized  IgG aggregates in the presence of LPS 
11595.  100 ~l of  various dilutions  of  IgG fractions  (see  Fig.  5)  was added to 50 ~l 250 pg/ml 
LPS R595 in saline,  and percent serotonin release  determined 15 rain  after  addition of  350- 
~l  platelet  suspension. Protein concentrations represent the  final  concentration in  the 500- 
~l mixture. Results are means of  duplicate  determinations  (e  ....  O, fraction  26; •  O, 
fraction  38; • .....  •, fraction  46). 
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FIG. 8.  Migration of various sized  IgG fractions  on sucrose density gradients. 0.4 ml of 
1311-1gG  fractions  from Fig. 5 was placed on 5-20% linear  sucrose gradients at the same 
time the experiments in Figs. 6 and 7 were performed.  They were then centrifuged at 
20,000 rpm for 18 h in a SW 50.1  rotor  at 4°C.  Fractions were collected  from the bottom of 
the tube.  Greater than 80% of  applied radioactivity  from each gradient was recovered. 
binds IgG aggregates (see fn. 2), these same fractions were analyzed on sucrose 
gradients in the presence of  LPS R595. All of  the radioactivity  in fraction  26 
was bound by the LPS whereas only 60% of  that  in  fraction  38 and none of  that 
in fraction  46 was bound.  The unbound material in fraction  38 formed a 
homogeneous 7S peak. Thus, protein concentrations  in fraction  38 were cor- 
rected  for monomer contamination by multiplying by 0.6.  These experiments 
indicate  that small and large  soluble  IgG aggregates are equally effective  on a 
weight basis  in  stimulating  the platelet,  and their  effects  are  equally  enhanced 
by LPS R595. These data suggest that simple increase  in the apparent size  of 
soluble  IgG aggregates is not sufficient  to explain enhanced cell  stimulation. 
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FIG.  9.  Effect of LPS R595 on platelet response to BSA-anti BSA immune complexes.  50 
~l of various dilutions of insoluble BSA-anti-BSA immune complexes was mixed with 50 
~l 0.9% NaC1 (©  ©) or 250 ~g/~l LPS R595 in 0.9% NaC1 (~----O). In addition, 50 ~l 
of dilutions of rabbit gamma globulin plus BSA in 0.9% NaC1 was added to 50 ~l 250 ftg/ml 
LPS R595  (I  •).  Percent serotonin release was determined 15 min ai~r  addition of 
400-pl platelet suspension. Mean _+ SEM of triplicate determinations. 
Complexes.  It  is  possible that  LPS  R595  acted  by  effectively insolubilizing 
soluble IgG aggregates. To rule this out, (since immune complexes have similar 
biologic properties to IgG aggregates and are initiators of tissue injury in vivo) 
the effect of LPS on platelet response to insoluble immune complexes was exam- 
ined. Fig. 9 shows the effect of LPS R595 on human platelet secretion induced by 
insoluble rabbit BSA-anti-BSA complexes. The LPS R595 induced a  25-fold en- 
hancement  in  platelet  sensitivity to these  immune  complexes,  but had  little 
effect on a  mixture of BSA and normal rabbit gamma globulin. 
Effect  of LPS  R595  on  Other  Platelet  Stimuli.  LPS  R595  and  lipid  A 
increased platelet sensitivity to aggregated IgG and immune complexes, leading 
us to examine their effects on other stimuli of platelet secretion. 
Fig.  10  shows  that  LPS  R595  slightly  inhibited  platelet  serotonin  release 
induced by a  proteolytic enzyme, thrombin,  a  negatively charged particle,  the 
monosodium  urate  crystal  (16),  or  antiplatelet  antibody.  The  response  to 
insoluble human  skin collagen was slightly enhanced.  In contrast,  as before, 
the  response to IgG aggregates  was  markedly  enhanced.  This  indicates  that 
LPS R595 does not engender a  state of "generalized cellular hypersensitivity" 
and that  its effects on platelet stimulation  are relatively specific for immune 
complexes. 
Discussion 
The  data  presented  in  this  report  show  that  the  common  lipid  region  of 
bacterial LPS markedly amplifies immune complex-induced platelet serotonin 
release. The release of radioactive serotonin as measured here, reflects the fate 
of the endogenous platelet amine  (22).  Synergistic release by LPS and aggre- M.  H.  GINSBERG  AND  P.  M.  HENSON 
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FIG.  10.  Effect of LPS R595 on other platelet stimuli. 50 ~1 of a  solution containing 500 
pg/ml LPS R595 in 0.9% NaC1 or 0.9% NaCI was added to 50/~1 of various concentrations 
of aggregated  IgG,  thrombin,  insoluble human  skin collagen,  antiplatelet antibody,  or 
monosedium urate  crystals in 0.9% NaCI.  Percent serotenin release was determined 15 
rain after addition of 400-~1 platelet suspension, mean _+ SEM of triplicate determinations. 
Concentrations  indicated  are  those  achieved  in  the  final  500-/~1 incubation  mixture 
(O  O, stimulus alone; C)  O, stimulus +  LPS R595). 
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gated IgG probably represents a true secretory reaction as  other granule constit- 
uents are released  3  and cytoplasmic LDH  is  retained under these circumstances. 
IgG monomer preparations  were some 50-fold  less  active  than aggregates in 
inducing platelet  serotonin release in the presence of  lipid  A or LPS R595. This 
may be the result either of minimal serotonin releasing activity  on the part of 
IgG monomer,  or a 2% contamination  (which would not have been detectable 
in our system)  of the  monomer  preparation  with  soluble IgG  aggregates. 
Heating monomer to 63°C markedly increased its activity  in inducing platelet 
serotonin release, and the activity was associated with aggregate-sized  mate- 
rial. Further,  heat-aggregated  myeloma  proteins were active, providing corn- 
polling evidence  that the activity of the LPS  was  expressed  via enhanced 
platelet sensitivity  to IgG aggregates,  and not through antilipid  A  antibodies 
or trace contaminants of  the protein. 
Aggregated IgG stimulates both platelet  (1) and neutrophil (23)  secretion.  In 
the latter case, small soluble aggregates have been reported to be virtually 
inactive, and this  activity  is  enhanced markedly when the size  of  the aggregates 
are increased or they are bound to surfaces (23).  In contrast to the neutrophil, 
we have shown that platelet  secretion is stimulated by very small soluble IgG 
aggregates  indicating a difference in the manner  in which these cell types 
respond  to  immune  aggregates.  The  effects of beth  large  and  small  IgG 
aggregates and insoluble immune  complexes  on platelets were enhanced  by 
LPS R595. This indicates that although LPS R595 binds immune  aggregates, 
the enhancement  of cell stimulation is not due to a simple increase  in the 
valence of  the stimulus as a result of  being enlarged or insolubilized. 
The ability  of immune  aggregates to bind and activate CI and to activate 
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platelets, the inhibition  of IgG aggregate-induced platelet  stimulation by CI 
(4),  and the reported presence of  CI activity  on washed platelets  (8) has led to 
the hypothesis that CI is a platelet  immunoglobulin receptor (8).  Lipid A  or 
LPS  R595,  potent activators of C~  (12, 13), had little  platelet stimulating 
activity  themselves. This indicates  that a molecule's  ability  to activate  CI does 
not always coincide  with the ability  to initiate  the release  reaction  of  washed 
human platelets.  The interaction  of  platelet-bound  C~ with LPS R595 or lipid  A 
might have played a role  in the enhancement of  platelet  response to immune 
aggregates, but the data presented  here do not permit one to favor this 
possibility above a wealth of others. What is clear is that these two potent 
activators  of  C1 are not potent platelet  stimuli  and that IgG4 aggregates, which 
do not activate  C~, stimulate the release  reaction  (4, 5). This implies different 
specificities between  the  Fc recognition unit of complement,  CI,  and the 
postulated  platelet  Fc receptor. 
Bacterial LPS  may  differ widely in biologic properties. One  important 
determinant of  these differences  is the relative  content of  lipid  A and polysac- 
charide (9).  Thus, polysaccharide-rich  LPS activates  primarily the alternative 
pathway of  complement, whereas lipid  A-rich LPS activates  primarily the clas- 
sical  pathway (12,  13).  Mueller-Eckhardt and Liischer  (24)  have reported that 
LPS from Escherichia coli 055:B5 failed to stimulate washed human platelets 
in the presence of a gamma globulin preparation. We have had similar results 
with  phenol  extracted  (15) polysaccharide-rich LPS  from E.  coli  055:B5.  4 
Because E.  coli  O55:B5 LPS  contains a  typical lipid  A  moiety, these data 
underscore modulation of lipid A effects by the polysaccharide constituent of 
LPS  and  the  importance  of using  well-characterized LPS  preparations  in 
defining specific LPS effects. 
LPS is capable of initiating a  wide variety of injurious responses in vivo. 
This may be a result of its ability to activate a number of mediation systems. 
Recently, it has become clear that the common lipid region of LPS alone may 
provide the LPS activation signal to many cells, such as murine B cells (25-28) 
and macrophages,  ~ and  human procoagulant activity generating leukocytes 
(29) and to humoral systems such as complement via C~  (12, 13). Strikingly, 
immune complexes have important effects on each of these systems as well (3, 
30, 31) and initiate a wide variety of injurious responses in vivo. The observation 
that the common lipid A moiety of LPS enhances a cell's response to immune 
complexes  may  then  provide  an  important  clue  to  the  mechanism of the 
multiplicity of LPS effects in vitro and in vivo. 
Summary 
The effect of the common lipid moiety of bacterial LPS on secretion from 
washed human platelets has been studied. The lipid A-rich LPS ofS. minnesota 
R595 and a lipid A preparation beth potentiated platelet serotonin secretion in 
response to IgG aggregates or immune complexes up to 50-fold but had little 
4 M. H. Ginsberg and D. C. Morrison. Manuscript in preparation. 
5  W.  F. Doe, S. T. Yang,  D. C.  Morrison,  S. J. Betz, and P. M.  Henson.  Macrophage 
stimulation by bacterial lipopolysaccharides.  If. Evidence for independent stimulation signals 
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effect  in  the  absence  of  IgG.  Lipid  A  has  been  shown  to  bind  immune 
aggregates,  raising  the  possibility  that  its  mechanism  of  action  involved 
effective enlargement or insolubilization of the aggregates. IgG aggregates of 
dimer to  tetramer  size  were  shown to  be  platelet  stimuli,  equivalent on  a 
weight basis to larger soluble aggregates. The effect of both sizes of aggregates 
on platelets were equally enhanced by the LPS, indicating that increased size 
of aggregates alone could not account for the effect of LPS. Similarly, because 
lipid  A-rich  LPS  enhanced  platelet  response  to  already  insoluble  immune 
complexes, its mechanism of action cannot simply be insolubilization of  immune 
aggregates.  These  LPS did  not enhance platelet stimulation by antiplatelet 
antibody, monosodium urate crystals, or thrombin and only slightly enhanced 
stimulation by insoluble human skin collagen. This indicates some stimulus 
specificity in the ability of LPS to increase platelet secretion. The enhancement 
of cell response to immune complexes by the common lipid region of LPS may 
represent a mechanism for the diverse effects of LPS in vivo and in vitro. 
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